Spirochromanone Cst-17 as a potent microtubule destabilizing agent showing anticancer effects in HeLa cells by binding to tubulin

Cst-17 is a potential MTA that triggers apoptosis by arresting HeLa cells at G2/M phase.

Authors

Institutions

Publication Details

Journal
Future Medicinal Chemistry
Published
2026-02-17
DOI
https://doi.org/10.1080/17568919.2026.2628554
Primary Topic
Microtubule and mitosis dynamics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Spirochromanone Cst-17 as a potent microtubule destabilizing agent showing anticancer effects in HeLa cells by binding to tubulin

Debabrata Ghosh Dastidar, Ranita Roy, Gopal Chakrabarti, Urmi Chatterji et al.
Future Medicinal Chemistry
Microtubule and mitosis dynamics
article

Spirochromanone Cst-17 as a potent microtubule destabilizing agent showing anticancer effects in HeLa cells by binding to tubulin

Debabrata Ghosh Dastidar, Ranita Roy, Gopal Chakrabarti, Urmi Chatterji, Adinarayana Nandikolla, Kondapalli Venkata Gowri Chandra Sekhar
article en

Abstract

Cst-17 is a potential MTA that triggers apoptosis by arresting HeLa cells at G2/M phase.

Future Medicinal ChemistryVol. 18(6)
University of Calcutta (IN), Birla Institute of Technology and Science, Pilani (IN)
Openalex Percentile: Top 54%
Microtubule and mitosis dynamics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.